Top compounds associated with response to E2F7


Feature Type Standardized
Nominal ANOVA
mRNA nelarabine CTRPv2 pan-cancer AAC 0.1 0.009
mRNA BMS-536924 CTRPv2 pan-cancer AAC -0.096 0.009
mRNA simvastatin CTRPv2 pan-cancer AAC 0.1 0.01
mRNA Crizotinib gCSI pan-cancer AAC 0.16 0.01
mRNA Erlotinib GDSC1000 pan-cancer AAC -0.13 0.01
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.093 0.01
mRNA RAF265 CCLE pan-cancer AAC 0.13 0.01
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.096 0.01
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.089 0.01
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.087 0.01
Download CSV